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This cross-sectional study was carried out with 1000 elderly outpatients assisted by a Basic Health District 
Unit (UBDS) from the Brazilian Public Health System (SUS) in the municipality of Ribeirão Preto. 
We analyzed the clinical, socioeconomic and pharmacoepidemiological profile of the elderly patients 
in order to identify factors associated with polypharmacy amongst this population. We used a truncated 
negative binomial model to examine the association of polypharmacy with the independent variables of 
the study. The software SAS was used for the statistical analysis and the significance level adopted was 
0.05. The most prevalent drugs were those for the cardiovascular system (83.4%). There was a mean 
use of seven drugs per patient and 47.9% of the interviewees used ≥7 drugs. The variables that showed 
association with polypharmacy (P value < 0.01) were female gender, age >75 years, self-medication, 
number of health problems, number of medical appointments, presence of adverse drug events, use of 
over-the-counter drugs, use of psychotropic drugs, lack of physical exercise and use of sweeteners. The 
exposition to all these factors justified the high prevalence of polypharmacy amongst the interviewees. 
These results showed the need to adopt clinical intervention and educational and managerial measures 
to analyze and promote rationality in the use of drugs amongst the elderly users of SUS.
Uniterms: Pharmacoepidemiology. Elderly/use of drugs. Polypharmacy. Drugs/rational use. Public 
Health System.
Este estudo transversal foi realizado por meio de entrevistas com 1000 idosos atendidos em uma Unidade 
Básica Distrital de Saúde (UBDS) do Sistema Único de Saúde (SUS) no município de Ribeirão Preto. 
Analisou-se o perfil clínico, socioeconômico e farmacoepidemiológico a fim de identificar os fatores 
associados à polifarmácia nessa população. Utilizou-se um modelo binomial negativo truncado para 
análise da associação da polifarmácia com as variáveis independentes do estudo. O software SAS foi 
utilizado para a análise estatística. O nível de significância adotado foi de 0,05. Os fármacos com maior 
prevalência de uso foram do sistema cardiovascular (83,4%). Observou-se média de, aproximadamente, 
sete fármacos por paciente e 47,9% dos entrevistados usavam >7 fármacos. As variáveis que apresentaram 
associação com a polifarmácia (p< 0,01) foram: mulheres, idade (>75 anos), automedicação, quantidade 
de problemas de saúde, número de consultas médicas, uso de medicamentos isentos de prescrição médica, 
uso de psicotrópicos, não realização de exercícios físicos e uso de adoçante. A exposição a todos esses 
fatores justifica a alta prevalência de polifarmácia entre os entrevistados. Os resultados mostraram a 
necessidade de adotar medidas de intervenção clínica e educacional e gerencial para analisar e promover 
a racionalização do uso de fármacos entre os idosos usuários do SUS.
Unitermos: Farmacoepidemiologia. Idoso/uso de medicamentos. Polifarmácia. Medicamentos/uso 
racional. Sistema Público de Saúde.
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INTRODUCTION
Population ageing is a process common to all 
countries throughout the World. In most of the developed 
countries, this process occurred slowly and gradually, 
however in emerging countries such as Brazil, this change 
in the age structure is occurring rapidly (Carvalho, Garcia, 
2003). This rapid change in the Brazilian aging process 
can be explained by improvements in the health conditions 
provided to the population in recent decades, which 
contributed to a significant reduction in overall mortality 
rates (IBGE, 2009). It has been estimated that by 2050, 
Brazil will be the fifth country in the World in the number 
of elderly citizens (United Nations, 2011), the elderly 
population representing 30% of the total population by 
that time in contrast to approximately 12% at the current 
moment (IBGE, 2010).
Although the change in the ageing process represents 
social development, it is important to consider that a lack 
of planning to deal with it can lead to social and economic 
problems in the health system (Chaimowicz, 1997). 
The elderly are considered special individuals from the 
pharmacotherapeutic point of view, showing physiological 
modifications that can alter the kinetics and/or dynamics 
of the drugs in the organism (Baldoni et al., 2010). Beside 
this, due to several synergic factors like age, educational 
level, general state of health and the presence of specific 
morbidities, the number of drugs consumed by the general 
population tends to increase with age (Janchawee et al., 
2005).
These aspects place the elderly population as a group 
of patients vulnerable to negative pharmacotherapeutic 
outcomes. For example, the increased number of drugs 
consumed, referred to as polypharmacy, raises the risk 
of pharmacotherapeutic problems amongst the elderly, 
mainly those related to drug-drug interactions and adverse 
reactions (Obreli-Neto, 2012a; Nguyen et al., 2006; Lai et 
al., 2009; Buck et al., 2009), with financial implications 
for the health system (Fulton, Allen, 2005).
In this context, pharmacoepidemiological studies 
are promising tools, which are accessible, low cost and 
obtain fast results for the planning and improvement of the 
quality of the health services. The results can be applied 
to promoting rational pharmacotherapy as well as making 
it feasible to direct possible technical interventions with 
respect to the health team, facilitating the adoption of 
structural and managerial measures to improve the public 
health system (Strom, 2000).
The aim of this study was to characterize the use 
of drugs and identify the clinical and socioeconomic-
demographic factors that may be associated with the 
occurrence of polypharmacy amongst the elderly 
outpatients assisted by Brazilian Public Health System 
(SUS).
METHODOLOGY
Study design and setting
This cross-sectional study was carried out in the 
Brazilian city of Ribeirão Preto from November 20th, 2008 
to May 20th, 2009. We collected information about the 
medications used by elderly outpatients assisted by SUS 
and attended by the pharmacy of the Basic Health District 
Unit (UBDS) in the western district of Ribeirão Preto 
at the Health Center School of the Faculty of Medicine 
of Ribeirão Preto of the University of São Paulo (CSE-
FMRP-USP). The city of Ribeirao Preto has an estimated 
population of 605 thousand inhabitants, 12.6% of the 
individuals being over 60 years of age. The unit mentioned 
above covers an area with an estimated population of about 
184 thousand inhabitants, with approximately 22,000 
being elderly (IBGE, 2010; SEADE 2012).
Subjects
The study population represented 5.67% of the 
elderly patients attended by the public health service from 
the district previously mentioned. The inclusion criteria 
were patients aged 60 years or older, from both sexes, and 
who obtained their medications from the pharmacy of the 
Basic Health Unit during the study period. The exclusion 
criteria were elderly patients unable to express themselves 
and those who sent another person to the pharmacy to pick 
up their medication.
Data collection
The patients were invited to take part in the study 
when they come to the pharmacy to withdraw their 
medication. Patients who accepted the invitation were 
interviewed by a researcher in an individual room. The 
interview followed a structured form previously developed 
by our research team. During the interview the researcher 
collected socio-demographic data (age, gender, educational 
level and employment situation), clinical data (general 
state of health, morbidities, practice of physical exercise, 
ingestion of caffeinated beverages and alcoholic beverages 
and smoking) and data about the pharmacotherapy used 
(name and number of drugs being used at the moment of 
the interview and consumed in the previous thirty days, both 
with and without a medical prescription).
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All the drugs consumed were classified according to 
the first level of the Anatomical-Therapeutical-Chemical 
Classification System (ATC) (WHO, 2011). Potential 
hazardous drug-drug interactions were investigated 
using the World Health Organization Model Formulary 
2008 drug interaction guide (WHO, 2008a). The Over 
the Counter (OTC) and psychotropic medications were 
identified by Resolution nº 138/2003 (Brasil, 2003) and 
Decree 344/98 (Brasil, 1998) and its updates according 
to National Health Surveillance Agency (Anvisa), 
respectively.
Data analysis
Descriptive statistics were used to analyze most 
variables and the results presented in terms of the absolute 
and relative frequency, mean ± standard deviation (SD) 
with 95% confidence intervals (95% CI).
In the statistical analysis, the number of drugs 
used per person was considered as a dependent variable. 
The number of drugs used per person was modeled by 
means of a truncated negative binomial distribution 
(Hilbe, 2011) and a truncated Poisson distribution, 
considering that this variable is a count data without 
zero values (Long, 1997). Poisson and binomial negative 
distributions are frequently used to fit count data, but 
these models assume that the dependent variable is an 
integer number including zero, and in the present study, 
the number of drugs used per person is always equal or 
greater than 1. Therefore the statistical analysis assumed 
truncated distributions, that is, probability distributions 
which do not assume zero values.
The inclusion of independent variables (gender, age, 
practice of physical exercise, use of sweeteners, health 
problems, the number of medical appointments scheduled 
for a one year period, use of psychotropic and over the 
counter drugs (OTC), and self-medication) in the model 
allowed for comparisons between groups of interest. The 
SAS software (Morel, Neerchal, 2012) was used in the 
statistical analysis and the level of significance adopted 
was 0.05.
Ethical approval
This project was approved by the Ethics Committee 
of CSE-FMRP-USP, protocol n.285/2008.
RESULTS
Socio-demographic characteristics
From November 20th, 2008 to May 20th, 2009, 1227 
elderly patients were invited to take part in the study. Of 
these 116 refused to take part and 111 did not attend the 
inclusion criteria. Thus 1000 patients were interviewed. 
The mean age of the study group was 69.8 (±6.5), with 
a higher prevalence of women (66.1%). The majority of 
the elderly patients had completed or nearly completed 
elementary school (70.2%) and were retired or pensioners 
(75.0%) (Table I).
TABLE I - Socio-demographic characteristics of the elderly outpatients, Ribeirão Preto-SP- Brazil, 2008/2009 (n= 1,000)
Total (%) Men (%) Women (%)
Age (years)
60 to 64 24.7 22.0 26.0
65 to 75 56.3 60.0 54.4
> 75 19.0 18.0 19.6
Educational level
Illiterate 12.7 9.4 14.4
Literate  3.7 2.1  4.5
Completed all or part of elementary school 70.2 70.5 70.0
Completed high school or higher 13.4 18.0 11.1
Employment situation
Retired/Pensioner 80.6 91.6 75.0
Housewife 14.3  1.7 20.7
Carry out some paid work 5.1 6.7 4.3
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Clinical data
A mean of 3.4 morbidities/patient was observed, 
with 42.7% of the elderly outpatients presenting four or 
more health problems, the following standing out as more 
prevalent: hypertension (72.8%), dyslipidemia (42.2%), 
diabetes mellitus (24.3%), insomnia (12.2%), depression 
(12%), backache (11.6%) and osteoporosis (11.6%).
About one third of the elderly outpatients (31.1%) 
practiced physical exercise at least three times a week and 
93.2% ingested caffeinated beverages, there being little 
difference between the genders for these variables. With 
respect to the ingestion of alcoholic beverages (33.9% vs 
9.8%) and smoking (12.3% vs 6.5%), both were greater 
amongst the male gender.
Drug therapy data
A total of 6,856 medications were used in the 
previous 30 days, 5,475 being prescribed medications 
and 1,381 self-medications. A mean value of 6.85 (± 3.4) 
drugs (prescribed and self-medicated) was found per 
patient (Figure 1), and sixty one percent of the population 
used more than five medications. Drugs that act on the 
cardiovascular system (ATC code C) were the most 
commonly used, followed by drugs that act on the 
Alimentary Tract and Metabolism (ATC code A) and 
Nervous System (ATC code N) (Table II).
Self-medication was reported by 30.9% of the 
elderly outpatients, with a greater prevalence amongst the 
female gender (34.8% vs 23.3%). The drugs most used 
in self medication were dipirone (14.3%), followed by 
caffeine (9.5%), diclofenac (6.8%), orfenadrin (5.6%), 
paracetamol (4.2%), acetylsalicylic acid (2.6%) and 
carisoprodol (1.7%). An analysis of potential interactions 
between the drugs used by the elderly outpatients produced 
243 potentially hazardous interactions, the majority 
being related to drugs that act on the cardiovascular 
system (ATC code C), the most prevalent being: 
enalapril and hydrochlorothiazide (n=127), enalapril and 
furosemide (n=29), nifedipine and propanolol (n=12) and 
acetylsalicylic acid and warfarin (n=11).
The statistical analysis provided evidence that the 
use of polypharmacy by the elderly was influenced by 
socio-demographic, clinical and pharmacotherapeutic 
factors (Table III).
DISCUSSION
Awareness of the pharmacoepidemiological profile 
of elderly patients can help in the development of health 
policies to guarantee patient safety. A high number of 
drugs consumed per patient were verified in our study, 
most of them acting on the cardiovascular system, 
with a high prevalence of potentially hazardous drug 
interactions. The practice of self-medication and the use 
of psychotropic drugs were common in our sample. The 
variables that showed association with polypharmacy 
(P value < 0.01) were female gender, age >75 years, 
self-medication, number of health problems, number of 
FIGURE 1 - Distribution of the total number of drugs used by the elderly outpatients interviewed, contained in prescriptions and 
self-medicated, Ribeirão Preto-SP-Brazil, 2008/2009, (n=1000).
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TABLE II - Frequency of drugs with greater prevalence of use amongst the elderly outpatients interviewed, Ribeirão Preto-SP, 
Brazil, 2008/2009 (n= 1,000)
First level ATC WHO Drugs (prescribed & self-medicated) Frequency (%)
C Cardiovascular system
Hydrochlorothiazide (C03AA03) - 37.7%
Sinvastatin (C10AA01) - 36.2%
Enalapril (C09AA02) - 27%
Captopril (C09AA01) - 18.8%
Propranolol (C07AA05) - 17.2%
83.4
A Alimentary tract and Metabolism 
Omeprazole (A02BC01) - 34.4%
Metformin (A10BA02) -17.8% 
Calcium carbonate (A12AA04) - 17%
64.3
N Nervous system 
Dipyrone (N02BB02) - 23.9%
Paracetamol (N02BE01) - 19.7%
Fluoxetine (N06AB03) - 9.1%
62.3
M Musculo-skeletal system Diclofenac (M01AB05) - 20.3% 50.1
B Blood and blood forming organs Aspirin (100mg) (B01AC06) - 37.2% 37.2
R Respiratory system Dexchlorpheniramine (R06AB02) - 9.6% 18.8
H Systemic hormonal preparations, except sex hormones and insulin Levotyroxine (H03AA01) - 11.0% 11.6
medical appointments, use of over-the-counter drugs, use 
of psychotropic drugs, lack of physical exercise and the 
use of sweeteners. This pharmacoepidemiological profile 
indicates the need for developing health care practices to 
guarantee patient safety.
The socio-demographic characteristics (age, gender, 
educational level and employment situation) of our 
sample were similar to those observed in other Brazilian 
population studies involving non-institutionalized elderly 
outpatients. Obreli-Neto et al. (2011), found a mean age of 
65.8 ± 5.8 years (range 60-88 years) and a high prevalence 
of woman (65.9%) in a study carried out in the Ourinhos 
microrregion, Sao Paulo State. In a study developed in 
Marília, Sao Paulo State, 42.9% of the elderly patients 
were between 60-69 years, 61.8% were female, most 
of them were illiterate or had incomplete elementary 
schooling (68.1%), and the basic health units were the 
health service most used (62.4%) (Marin et al., 2008). 
A study carried out in the city of Rio de Janeiro found 
a total of 41.1% elderly patients between 60-69 years, 
60.6% being female, most of them had some elementary 
schooling (50.8%) and no private health coverage (56.9%) 
(Rozenfeld, Fonseca, Acurcio, 2008). It is important to 
consider the low educational level of the Brazilian elderly, 
since this is one of the factors interfering in adherence to a 
pharmacological treatment (Vermeire et al., 2001), in the 
use of inappropriate drugs and in polypharmacy (Haider 
et al., 2009).
Similar to previous Brazilian studies, our sample 
presented a high prevalence of chronic diseases, with 
hypertension, diabetes and dyslipidemia being the most 
common ones (Rozenfeld, Fonseca, Acurcio, 2008, 
Obreli-Neto et al., 2011, Obreli-Neto et al., 2012b). The 
high prevalence of chronic diseases is onerous for the 
health system, a fact also encountered in other studies 
with elderly patients (Leite-Cavalcanti et al., 2009; 
Crentsil et al., 2010), and should serve as an alert for 
health service planning due to the process of population 
ageing, since chronic diseases require continuous 
treatment and monitoring (Abegunde, Stanciole, 2006). 
For example, it is estimated that more than US$ 471 
billion were spent worldwide on healthcare for diabetes 
in 2012 for all age groups, with the greatest diabetes 
mellitus–associated health resource use attributed to 
the population aged >65 (Hagan, Dall, Nikolov, 2003; 
IDF, 2012). Our study also verified a lack of practice 
of physical activities and an elevated ingestion of 
caffeinated and alcoholic beverages, and smoking. The 
use of these social drugs can influence negatively in 
the search for positive therapeutic outcomes for these 
chronic diseases.
The mean number of drugs used by the elderly 
outpatients was higher than that found in other studies 
carried out with patients in the same age range (Flores, 
Mengue, 2005; Danilow et al., 2007; Barry et al., 
2006; Gallagher, Mahony, 2008). It was notable that 
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approximately 48% of the interviewees used more 
than six drugs, whilst in another Brazilian study this 
prevalence was only 11% (Rozenfeld, Fonseca, Acurcio, 
2008). This high number of drugs used favored the risk 
of problems related to pharmacotherapy, such as drug 
interactions (Janchawee et al., 2005), adverse drug 
reactions (Nguyen et al., 2006; Obreli-Neto et al., 2012a) 
and the use of inappropriate drugs (Buck et al., 2009; 
Lai et al., 2009).
The high prevalence of the use of drugs for the 
cardiovascular system stands out amongst the similarities 
for the use of drugs in this age range (Ribeiro et al., 2008; 
Crentsil et al., 2010; Correr et al., 2007). Drugs that 
act on the cardiovascular system are important causes 
of adverse drug reactions (ADR) amongst the elderly, 
mainly affecting the central nervous system and the 
gastrointestinal and vascular systems (Mohebbi et al., 
2010; Faulx MD, Francis, 2008), which suggests the 
TABLE III - Mean number of drugs used per elderly outpatient with its respective 95% confidence interval (95%CI), estimates of the 
mean difference between groups (with 95%CI), and crude and adjusted P values obtained using truncated negative binomial models
Mean 95%CI
Difference between means
Estimate (95%CI) Crude P value
Adjusted
P value
Gender
 Males 5.62 (5.32,5.93)
1.84 (1.43,2.25) <.01 <.01 (a)
 Females 7.48 (7.20,7.75)
Age Range (years)
 60 to 64 6.56 (6.14,6.97) Reference
 65 to 69 6.69 (6.30,7.09) 0.13 (-0.43,0.71) 0.64 0.54 (b)
 70 to 74 6.98 (6.54,7.41) 0.42 (-0.17,1.02) 0.17 0.05 (b)
 75 or older 7.23 (6.75,7.71) 0.67 (0.04,1.30) 0.04 <.01 (b)
Self-medication
 No 6.24 (6.01,6.48)
1.95 (1.47,2.44) <.01 <.01 (c)
 Yes 8.20 (7.77,8.63)
Health problems
 Up to 3 5.29 (5.08,5.49)
3.66 (3.38,4.05) <.01 <.01 (c)
 More than 3 8.95 (8.62,9.28)
Medical appointments made
 Up to 4 6.36 (6.12,6.60)
1.64 (1.14,2.13) <.01 <.01 (c)
 More than 4 8.00 (7.57,8.43)
Use of OTC
 No 4.14 (3.83,4.14)
3.38 (3.00,3.77) <.01 <.01 (c)
 Yes 7.52 (7.29,7.75)
Takes physical exercise
 No 7.11 (6.82,7.40)
-0.64 (-1.07,0.22) <.01 0.02 (c)
 Yes 6.47 (6.15,6.79)
Uses sweeteners
 No 6.43 (6.18,6.68)
1.18 (0.72,1.64) <.01 <.01 (c)
 Yes 7.62 (7.23,8.00)
Use of Psychotropic drugs
 No 6.18 (5.93,6.42)
1.88 (1.42,2.33) <.01 <.01 (c)
 Yes 8.05 (7.66,8.44)
(a) Adjusted by age; (b) Adjusted by gender; (c) Adjusted by age and gender; OTC: Over-the-counter drugs; ADE: Adverse drug event
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need for appropriate medication therapy management in 
these patient to prevent and detect negative therapeutic 
outcomes early. Drugs that act on the alimentary tract 
and metabolism and on the nervous system are also 
frequently prescribed in our study and in other Brazilian 
studies. These ATC codes were also frequently involved 
in adverse drug reactions in elderly outpatients (Gurwitz 
et al., 2003).
Dypirone was the drug most frequently used in 
self-medication, followed by caffeine and diclofenac. 
Considering these drugs used for self-medication, the 
use of non-steroidal anti-inflammatory drugs (NSAID) 
stands out. NSAIDs show considerable potential for drug 
interactions (Micromedex, 2011) and adverse reactions, 
such as an increase in cardiovascular risk (Hudson, 
Richard, Pilote, 2005) and increases in renal dysfunction 
in patients with chronic kidney disease, a condition that 
tends to occur with greater incidence in elderly patients 
(Kuo et al., 2010). Apart from the NSAIDs, the use of 
carisoprodol should also be highlighted, since this drug 
is considered inappropriate for the elderly, on account of 
it showing a high risk of causing anticholinergic adverse 
effects, sedation, weakness and risk of fractures (American 
Geriatrics Society, 2012).
In the present study, the statistical analysis indicated 
that polypharmacy was probably multifactorial. Different 
to the study of Hovstadius et al. (2010), we found that 
female sex was a predictor of polypharmacy, whereas 
when we observe the age, the data corroborate with 
those in the literature, the use of drugs increasing with 
increasing age (> 75 years) (Janchawee et al., 2005; 
Hovstadius et al., 2010; Bardel, Wallander, Svardsudd, 
2000). However another Brazilian study carried out with 
institutionalized elderly subjects found no association 
between polypharmacy and increasing age amongst the 
three age ranges analyzed (Lucchetti et al., 2010). These 
divergent findings suggest that polypharmacy has regional 
characteristics.
The absence of physical activity amongst the elderly 
can be considered as an indicator of polypharmacy, 
corroborating with available data which shows that the 
practice of physical exercises reduces the risk of chronic 
diseases (Haskell et al., 2007), which can hence reduce 
the need for drug use (Veehof et al., 2000).
The number of health problems was the most 
important statistical indicator of polypharmacy, 
hypertension and diabetes mellitus being the most common 
ones. Previous studies identified these morbidities as 
indicators that favored the use of polypharmacy amongst 
the elderly (Rozenfeld, Fonseca, Acurcio, 2008), which 
confirms the strong correlation between polypharmacy 
and the number of health problems found in our study. 
In addition, we found that the use of sweeteners had a 
significant relationship with polypharmacy. However, it is 
important to consider that this could be associated with the 
presence of diabetes mellitus, since this morbidity favors 
the use of various drugs (Rozenfeld, Fonseca, Acurcio, 
2008; Veehof et al., 2000).
The number of medical appointments is a well-
known indicator of polypharmacy (Haider et al., 2008; 
Rozenfeld, Fonseca, Acurcio, 2008), nevertheless in 
clinical practice this evidence deserves a critical evaluation 
of the rationality of pharmacotherapy, since in geriatrics 
a physiological alteration inherent to the ageing process 
can be confounded with a health problem, leading to an 
unnecessary prescription.
Analyzing the drug categories used by the elderly, it 
can be seen that the use of OTCs and of psychotropic drugs 
was also correlated with polypharmacy. The relationship 
of polypharmacy with the use of OTCs could be related to 
self-medication, since the drugs in this category were those 
showing the greatest prevalence of use amongst those 
not prescribed by a doctor. Moreover, it is important to 
remember that the use of polypharmacy and psychotropic 
drugs together are risk factors for falls in elderly patients 
(Baranzini et al., 2009).
Considering the consequences of polypharmacy to 
the health of the elderly, it is important to highlight the 
need for new studies that evaluate if all the drugs used 
by the elderly justify the clinical indication (Rozenfeld, 
Fonseca, Acurcio, 2008). If on one hand the use of various 
medications could indicate the guarantee of access to the 
medication, on the other hand it could indicate excessive 
and irrational use. These questions provide an impulse 
for new investigations and new hypotheses to be tested 
by analytical studies.
CONCLUSIONS
From the data obtained in the interviews with the 
elderly outpatients, it was observed that they were exposed 
to various factors that could have contributed to the use 
of polypharmacy, such as a high prevalence of health 
problems, elevated number of doctors’ appointments, 
self-medication, and the use of psychotropic drugs and 
OTC. The exposition to all these factors justified the high 
prevalence of polypharmacy amongst the interviewees, 
with 47.9% using more than six drugs. This showed the 
need to adopt clinical intervention and educational and 
managerial measures to analyze and promote rationality in 
the use of drugs amongst the elderly users of the Brazilian 
Public Health System.
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